SOFIE Breaks Ground On 30,000 Sq Ft Theranostic Center Of Excellence
TOTOWA, N.J., June 24, 2019 /PRNewswire/ — SOFIE Inc. (SOFIE), a Theranostics company headquartered in Los Angeles, CA, […]
SOFIE and University Clinic Heidelberg Sign License Agreement
SOFIE and University Clinic Heidelberg Sign License Agreement for Theranostics That Target Cancer Associated […]
SOFIE Expands Its Network By Acquiring Cyclotope Radiopharmacy From Houston Cyclotron Partners
HOUSTON, June 17, 2019 — Los Angeles-based SOFIE Inc. (SOFIE), a molecular imaging and theranostic company, […]
SOFIE is Awarded $5M from Three Major SBIR Grants
CULVER CITY, Calif., Oct. 5, 2018 — Today SOFIE, an emerging theranostics company focused on […]
Acquisition of Zevacor Pharma Complete
September 27th 2017 Culver City, CA – Sofie Biosciences, Inc., the molecular imaging company specializing […]
SOFIE to Acquire Zevacor Pharma
Thursday, May 11, 2017 Sofie Biosciences, Inc., (Culver City, CA) announced today that it has […]
SOFIE receives $1.5M NCI Phase II SBIR
Original post: http://goo.gl/Li4BGt CULVER CITY, Calif., Oct. 16, 2014 /PRNewswire/ — SOFIE […]
SOFIE Receives $1.8M Phase II SBIR Grant
CULVER CITY, CA., October 2nd, 2013 – SOFIE BIOSCIENCES, an emerging in vivo imaging […]
SOFIE Receives $1M Phase II SBIR Grant
CULVER CITY, Calif., July 11, 2012 — Sofie Biosciences, Inc., a molecular imaging company offering […]